Amendment 0004 Solicitation SPE2D2-24-R-0016(Bicalutamide) CANCELLED
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-24-R-0016
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents4
The Defense Logistics Agency (DLA) Troop Support, a federal office responsible for supplying critical materials to various government entities, issued Solicitation SPE2D2-24-R-0016 for a national requirements contract to procure Bicalutamide 50MG tablets. However, as of July 10, 2024, Amendment 0004 has officially cancelled this solicitation in its entirety.
Originally, the procurement sought to establish a firm-fixed price, requirements-type contract with a one-year base period and four one-year option periods. The contract was intended to serve as a national supply source for Bicalutamide 50MG tablets, specifically in bottle counts of 30 and 500. The estimated annual quantities were 23,529 bottles of the 30-count and 1,961 bottles of the 500-count. These pharmaceuticals were to be made available for purchase by the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs.
The acquisition was classified as unrestricted and fully competitive, allowing all qualified sources to submit proposals. The procurement was designated as a commercial item under FAR Part 12, with the applicable NAICS code being 325412 (Pharmaceutical Preparation Manufacturing, 2022 version) and Product Service Code 6505. The place of performance was specified as the United States.
Interested parties were directed to monitor the DLA Bid Board System (DIBBS) and SAM.gov for updates and to contact Keith Ryales ([email protected], 215-737-9199) for further information. The solicitation included instructions for accessing embedded documents and amendments, with a previously established closing date of February 7, 2025, at 3:00 pm.
Despite the comprehensive scope and clear objectives outlined in the original solicitation, Amendment 0004 has rendered the opportunity inactive, cancelling all associated requirements and deliverables. Contractors should note that this procurement is no longer available, and any prior amendments or documents related to this solicitation are now void. For future opportunities or updates, interested parties are encouraged to maintain automated notifications through the official procurement websites and remain in contact with the designated contracting officer.
Key details that remain constant for similar future opportunities include the contracting entity (DLA Troop Support), the nature of the requirement (pharmaceutical supply for federal agencies), the competitive and unrestricted procurement approach, and the use of firm-fixed price, requirements-type contracts. The NAICS and PSC codes, as well as the primary point of contact, are also likely to remain relevant for comparable solicitations.